Moores Cancer Center, University of California, San Diego, 3855 Health Sciences Dr., #0901, La Jolla, CA, 92093-0829, USA.
Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, USA.
Breast Cancer Res Treat. 2017 Nov;166(1):185-193. doi: 10.1007/s10549-017-4389-z. Epub 2017 Jul 11.
To assess tumor subtype distribution and the relative contribution of clinical and sociodemographic factors on breast cancer survival between Hispanic and non-Hispanic whites (NHWs).
We analyzed data from the California Cancer Registry, which included 29,626 Hispanic and 99,862 NHW female invasive breast cancer cases diagnosed from 2004 to 2014. Logistic regression was used to assess ethnic differences in tumor subtype, and Cox proportional hazard modeling to assess differences in breast cancer survival.
Hispanics compared to NHWs had higher odds of having triple-negative (OR = 1.29; 95% CI 1.23-1.35) and HER2-overexpressing tumors (OR = 1.19; 95% CI 1.14-1.25 [HR-] and OR = 1.39; 95% CI 1.31-1.48 [HR+]). In adjusted models, Hispanic women had a higher risk of breast cancer mortality than NHW women (mortality rate ratio [MRR] = 1.24; 95% CI 1.19-1.28). Clinical factors accounted for most of the mortality difference (MRR = 1.05; 95% CI 1.01-1.09); however, neighborhood socioeconomic status (SES) and health insurance together accounted for all of the mortality difference (MRR = 1.01; 95% CI 0.97-1.05).
Addressing SES disparities, including increasing access to health care, may be critical to overcoming poorer breast cancer outcomes in Hispanics.
评估西班牙裔和非西班牙裔白人(NHW)之间乳腺癌肿瘤亚型分布以及临床和社会人口因素对乳腺癌生存的相对贡献。
我们分析了加利福尼亚癌症登记处的数据,该数据包括 2004 年至 2014 年间诊断出的 29626 例西班牙裔和 99862 例 NHW 女性浸润性乳腺癌病例。使用逻辑回归评估肿瘤亚型的种族差异,使用 Cox 比例风险模型评估乳腺癌生存的差异。
与 NHW 相比,西班牙裔患者具有更高的三阴性(OR=1.29;95%CI 1.23-1.35)和 HER2 过表达肿瘤(OR=1.19;95%CI 1.14-1.25 [HR-]和 OR=1.39;95%CI 1.31-1.48 [HR+])的可能性。在调整后的模型中,西班牙裔女性的乳腺癌死亡率高于 NHW 女性(死亡率比 [MRR] = 1.24;95%CI 1.19-1.28)。临床因素解释了大部分死亡率差异(MRR=1.05;95%CI 1.01-1.09);然而,邻里社会经济地位(SES)和健康保险共同解释了所有死亡率差异(MRR=1.01;95%CI 0.97-1.05)。
解决 SES 差距,包括增加获得医疗保健的机会,对于克服西班牙裔乳腺癌较差的预后可能至关重要。